Predicting Oncotype DX scores using clinicopathologic features: A report from the National Cancer Database.

被引：2
|
作者：
Pesce, Catherine
Kuchta, Kristine
Erdogan, Beyza
Wang, Chihsiung
Yao, Katharine
El-Tamer, Mahmoud
机构：
[1] NorthShore Univ Hlth Syst, Dept Surg, Evanston, IL USA
[2] NorthShore Univ Hlth Syst, Evanston, IL USA
[3] NorthShore Univ HealthSyst, Evanston, IL USA
[4] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
551
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Predicting Oncotype DX recurrence scores using clinicopathologic features: Tennessee University Nomogram: An external validation
    Pikabea Diaz, F.
    Galve Calvo, E.
    Zumarraga, A.
    Figaredo Bejarano, C.
    Sala Gonzalez, M. A.
    Lopez Santillan, M.
    De San Vicente, B. Lopez
    Casado, P.
    Martinez del Prado, M. P.
    ANNALS OF ONCOLOGY, 2022, 33 : S233 - S233
  • [2] Practice patterns and outcomes for hormone receptor positive and node negative breast cancer patients with intermediate risk Oncotype DX scores: Analysis of the National Cancer Database.
    Chen, Jonathan
    Wu, Xian
    Christos, Paul J.
    Nori, Dattatreyudu
    Formenti, Silvia
    Nagar, Himanshu
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer
    Felts, Jesse L.
    Zhu, Junjia
    Han, Bing
    Smith, Stanley J.
    Truica, Cristina I.
    BREAST JOURNAL, 2017, 23 (06): : 677 - 686
  • [4] A model to predict high-risk Oncotype DX scores as defined by the TailorX trial: A report from the National Cancer Data Base
    Pesce, C.
    Kuchta, K.
    Wang, E.
    Yao, K.
    El-Tamer, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [5] Verification of a Western Nomogram for Predicting Oncotype DX™ Recurrence Scores in Korean Patients with Breast Cancer
    Kim, Jae-Myung
    Ryu, Jai Min
    Kim, Isaac
    Choi, Hee Jun
    Nam, Seok Jin
    Kim, Seok Won
    Yu, Jonghan
    Lee, Se Kyung
    Lee, Jeong Eon
    JOURNAL OF BREAST CANCER, 2018, 21 (02) : 222 - 226
  • [6] Adherence Disparities and Utilization Trends of Oncotype DX Assay: A National Cancer Database Study
    Chen, Shuyi
    Thacker, Christopher
    Wang, Shengxuan
    Young, Katelyn A.
    Hoffman, Rebecca L.
    Blansfield, Joseph A.
    JOURNAL OF SURGICAL RESEARCH, 2023, 286 : 65 - 73
  • [7] Clinicopathologic characterization and outcomes for patients with renal medullary carcinoma: Results from the National Cancer Database.
    Zaid, Harras B.
    Thompson, Robert Houston
    Leibovich, Bradley C.
    Parker, William P.
    Costello, Brian Addis
    Pagliaro, Lance C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [8] ONCOTYPE DX® VS CLINICOPATHOLOGIC FACTORS IN BREAST CANCER: THE EXPERIENCE FROM GREECE AND CYPRUS
    Nasioulas, G.
    Kesisis, G.
    Razi, E.
    Athanasiades, I.
    Ardavanis, A.
    Simpilidis, G.
    Skarlos, D.
    Boukovinas, I.
    Kakouri, E.
    Andreadis, H.
    Georgoulias, V.
    BREAST, 2013, 22 : S68 - S69
  • [9] Comparing practice patterns and outcomes for early-stage hormone receptor-positive and node-positive breast cancer patients with high-intermediate-risk Oncotype Dx scores in the National Cancer Database.
    Tamragouri, Keerthi
    Ritz, Ethan M.
    Rao, Ruta D.
    O'Donoghue, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Epidemiology, clinical features and outcomes of ganglioneuroblastoma: An analysis of the National Cancer Database.
    Nelson, Bridgett
    Silberstein, Peter T.
    Cichon, Gregory
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345